CVS Health EBIT Margin 2010-2025 | CVS
Current and historical EBIT (Earnings Before Interest & Taxes) margin for CVS Health (CVS) over the last 10 years. The current EBIT profit margin for CVS Health as of March 31, 2025 is .
| CVS Health EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-03-31 | $378.96B | $9.62B | 2.54% |
| 2024-12-31 | $372.81B | $8.52B | 2.28% |
| 2024-09-30 | $368.91B | $9.52B | 2.58% |
| 2024-06-30 | $363.25B | $12.38B | 3.41% |
| 2024-03-31 | $360.94B | $12.57B | 3.48% |
| 2023-12-31 | $357.78B | $13.74B | 3.84% |
| 2023-09-30 | $347.81B | $14.03B | 4.03% |
| 2023-06-30 | $339.20B | $6.42B | 1.89% |
| 2023-03-31 | $330.92B | $7.86B | 2.37% |
| 2022-12-31 | $322.47B | $7.95B | 2.47% |
| 2022-09-30 | $315.23B | $6.64B | 2.11% |
| 2022-06-30 | $307.86B | $13.62B | 4.42% |
| 2022-03-31 | $299.84B | $13.28B | 4.43% |
| 2021-12-31 | $292.11B | $13.31B | 4.56% |
| 2021-09-30 | $285.06B | $13.49B | 4.73% |
| 2021-06-30 | $278.32B | $13.68B | 4.91% |
| 2021-03-31 | $271.05B | $14.03B | 5.18% |
| 2020-12-31 | $268.71B | $13.91B | 5.18% |
| 2020-09-30 | $266.04B | $14.42B | 5.42% |
| 2020-06-30 | $263.80B | $14.10B | 5.35% |
| 2020-03-31 | $261.89B | $12.76B | 4.87% |
| 2019-12-31 | $256.78B | $11.99B | 4.67% |
| 2019-09-30 | $244.31B | $9.77B | 4.00% |
| 2019-06-30 | $226.99B | $9.42B | 4.15% |
| 2019-03-31 | $210.48B | $4.72B | 2.24% |
| 2018-12-31 | $194.58B | $4.02B | 2.07% |
| 2018-09-30 | $188.56B | $6.33B | 3.35% |
| 2018-06-30 | $187.25B | $6.25B | 3.34% |
| 2018-03-31 | $186.02B | $9.74B | 5.24% |
| 2017-12-31 | $184.79B | $9.54B | 5.16% |
| 2017-09-30 | $182.37B | $9.43B | 5.17% |
| 2017-06-30 | $180.81B | $9.75B | 5.39% |
| 2017-03-31 | $178.85B | $9.99B | 5.59% |
| 2016-12-31 | $177.55B | $10.39B | 5.85% |
| 2016-09-30 | $172.70B | $10.12B | 5.86% |
| 2016-06-30 | $166.73B | $9.62B | 5.77% |
| 2016-03-31 | $160.17B | $9.53B | 5.95% |
| 2015-12-31 | $153.29B | $9.48B | 6.18% |
| 2015-09-30 | $149.20B | $9.05B | 6.06% |
| 2015-06-30 | $145.58B | $8.96B | 6.16% |
| 2015-03-31 | $143.01B | $8.91B | 6.23% |
| 2014-12-31 | $139.37B | $8.80B | 6.31% |
| 2014-09-30 | $135.14B | $8.70B | 6.43% |
| 2014-06-30 | $132.05B | $8.60B | 6.51% |
| 2014-03-31 | $128.70B | $8.37B | 6.50% |
| 2013-12-31 | $126.76B | $8.04B | 6.34% |
| 2013-09-30 | $125.31B | $8.10B | 6.47% |
| 2013-06-30 | $123.61B | $7.76B | 6.28% |
| 2013-03-31 | $123.07B | $7.50B | 6.09% |
| 2012-12-31 | $123.12B | $7.21B | 5.86% |
| 2012-09-30 | $120.04B | $6.88B | 5.73% |
| 2012-06-30 | $116.48B | $6.65B | 5.71% |
| 2012-03-31 | $112.18B | $6.43B | 5.73% |
| 2011-12-31 | $107.08B | $6.33B | 5.91% |
| 2011-09-30 | $103.08B | $6.12B | 5.94% |
| 2011-06-30 | $100.12B | $6.02B | 6.01% |
| 2011-03-31 | $97.71B | $6.03B | 6.17% |
| 2010-12-31 | $95.78B | $6.14B | 6.41% |
| 2010-09-30 | $96.79B | $6.27B | 6.48% |
| 2010-06-30 | $97.72B | $6.36B | 6.51% |
| 2010-03-31 | $98.58B | $6.46B | 6.55% |
| 2009-12-31 | $98.22B | $6.43B | 6.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.883B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.273B | 26.50 |
| Elevance Health (ELV) | United States | $94.057B | 12.14 |
| Cencora (COR) | United States | $56.618B | 20.55 |
| Natera (NTRA) | United States | $21.276B | 0.00 |
| DiDi Global (DIDIY) | China | $19.908B | 30.21 |
| BioMerieux (BMXMF) | France | $15.658B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.897B | 0.00 |
| Solventum (SOLV) | United States | $11.572B | 10.79 |
| ICON (ICLR) | Ireland | $11.550B | 10.74 |
| CochLear (CHEOY) | Australia | $11.542B | 0.00 |
| Revvity (RVTY) | United States | $11.153B | 18.83 |
| Doximity (DOCS) | United States | $11.088B | 57.66 |
| Viatris (VTRS) | United States | $10.187B | 3.24 |
| Medpace Holdings (MEDP) | United States | $8.637B | 22.94 |
| Avantor (AVTR) | United States | $8.606B | 12.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.908B | 38.90 |
| Charles River Laboratories (CRL) | United States | $5.866B | 11.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.018B | 23.69 |
| BrightSpring Health Services (BTSG) | United States | $3.685B | 34.11 |
| Sotera Health (SHC) | United States | $3.667B | 20.84 |
| Alignment Healthcare (ALHC) | United States | $3.063B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.009B | 34.51 |
| Concentras Parent (CON) | United States | $2.767B | 14.39 |
| Organon (OGN) | United States | $2.267B | 2.41 |
| Progyny (PGNY) | United States | $2.005B | 44.15 |
| Ardent Health Partners (ARDT) | United States | $1.880B | 0.00 |
| Premier (PINC) | United States | $1.873B | 11.99 |
| GeneDx Holdings (WGS) | United States | $1.857B | 72.70 |
| GoodRx Holdings (GDRX) | United States | $1.799B | 39.08 |
| Agilon Health (AGL) | United States | $1.702B | 0.00 |
| PACS (PACS) | United States | $1.536B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.254B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.111B | 9.32 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.967B | 0.00 | |
| CareDx (CDNA) | United States | $0.845B | 13.19 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 6.01 |
| Embecta (EMBC) | United States | $0.724B | 4.96 |
| Nutex Health (NUTX) | United States | $0.720B | 14.10 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 13.67 |
| Sonida Senior Living (SNDA) | United States | $0.447B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 37.95 |
| InnovAge Holding (INNV) | United States | $0.391B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.375B | 0.00 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| SBC Medicals (SBC) | United States | $0.320B | 0.00 |
| DocGo (DCGO) | United States | $0.240B | 9.79 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.186B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.078B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| ModivCare (MODV) | United States | $0.020B | 7.05 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |